Viewing Study NCT00792467


Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2025-12-27 @ 12:10 PM
Study NCT ID: NCT00792467
Status: COMPLETED
Last Update Posted: 2021-05-11
First Post: 2008-11-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma
Sponsor: Italfarmaco
Organization: